Your browser doesn't support javascript.
loading
Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study.
Kostikas, Konstantinos; Greulich, Timm; Mackay, Alexander J; Lossi, Nadine S; Aalamian-Mattheis, Maryam; Nunez, Xavier; Pagano, Veronica A; Patalano, Francesco; Clemens, Andreas; Vogelmeier, Claus F.
Afiliação
  • Kostikas K; Respiratory Medicine Dept, University of Ioannina, Ioannina, Greece.
  • Greulich T; Dept of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Member of the German Center for Lung Research (DZL), Giessen, Germany.
  • Mackay AJ; Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
  • Lossi NS; Novartis Pharma GmbH, Nuremberg, Germany.
  • Aalamian-Mattheis M; Novartis Pharma AG, Basel, Switzerland.
  • Nunez X; TFS Develop, Barcelona, Spain.
  • Pagano VA; TFS Develop, Barcelona, Spain.
  • Patalano F; Novartis Pharma AG, Basel, Switzerland.
  • Clemens A; Novartis Pharma AG, Basel, Switzerland.
  • Vogelmeier CF; Dept of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
ERJ Open Res ; 5(1)2019 Feb.
Article em En | MEDLINE | ID: mdl-30815470

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ERJ Open Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ERJ Open Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia